6-amino-1-hydroxyhexane-1,1-diphosphonate and Spondylitis, Ankylosing

6-amino-1-hydroxyhexane-1,1-diphosphonate has been researched along with Spondylitis, Ankylosing in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adami, S; Fracassi, E; Gatti, D; Idolazzi, L; Povino, MR; Rossini, M; Troplini, S; Viapiana, O	1

Trials

1 trial(s) available for 6-amino-1-hydroxyhexane-1,1-diphosphonate and Spondylitis, Ankylosing

Article	Year
Bisphosphonates vs infliximab in ankylosing spondylitis treatment. Rheumatology (Oxford, England), 2014, Volume: 53, Issue:1 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Bone Density Conservation Agents; Diphosphonates; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Infliximab; Injections, Intravenous; Male; Middle Aged; Pain Measurement; Spondylitis, Ankylosing; Treatment Outcome; Tumor Necrosis Factor-alpha	2014

Article

Year

Bisphosphonates vs infliximab in ankylosing spondylitis treatment.

Rheumatology (Oxford, England), 2014, Volume: 53, Issue:1

Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Bone Density Conservation Agents; Diphosphonates; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Infliximab; Injections, Intravenous; Male; Middle Aged; Pain Measurement; Spondylitis, Ankylosing; Treatment Outcome; Tumor Necrosis Factor-alpha

2014